Kapil Mayawala

Kapil Mayawala has extensive work experience in the pharmaceutical industry. Kapil is currently serving as the Vice President of Clinical Pharmacology and Clinical Development at Generate Biomedicines. Before joining Generate Biomedicines, Kapil held various roles at Merck, including Distinguished Scientist/Executive Director of Oncology Clinical Development and Senior Director of Oncology Clinical Development. Kapil was also a Director and Group Leader in the Oncology department at Merck. Prior to their time at Merck, Kapil worked at Pfizer as a Senior Principal Scientist and Principal Scientist in Biologics Preclinical Development. Kapil began their career as a Research Investigator in Systems Biology at Novartis.

Kapil Mayawala's education history includes attending the University of Chicago, Indian Institute of Technology (IIT), Kanpur, and the University of Delaware. However, specific details such as degrees or fields of study are not provided.